Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

about

Neutral tumor evolution in myeloma is associated with poor prognosis.Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma.

P2860

Q38615431-9F2D7B2F-32F7-4546-B57C-BCE6FF2E64C8 Q50057730-7D1D5593-C9DD-4646-9761-CC3350DBA9A3 Q52646188-40D6CE68-790B-4561-82D3-8A71E29F9F8E

P2860

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Item

http://www.wikidata.org/entity/Q38742055

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en-gb

type

Item

label

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en-gb

prefLabel

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en

Prediction of outcome in newly ...... ofiles of 1905 trial patients.

@en-gb

P1154

2-s2.0-85044620380

http://www.w3.org/2001/XMLSchema#string

P1433

Leukemia

P1476

Prediction of outcome in newly ...... rofiles of 1905 trial patients

@en

P2093

D B Begum

http://www.w3.org/2001/XMLSchema#string

G H Jackson

http://www.w3.org/2001/XMLSchema#string

J R Jones

http://www.w3.org/2001/XMLSchema#string

M F Kaiser

http://www.w3.org/2001/XMLSchema#string

P Z Proszek

http://www.w3.org/2001/XMLSchema#string

R G Owen

http://www.w3.org/2001/XMLSchema#string

S Ellis

http://www.w3.org/2001/XMLSchema#string

V Shah

http://www.w3.org/2001/XMLSchema#string

W M Gregory

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors

Prognostic significance of copy-number alterations in multiple myeloma

NF-κB, the first quarter-century: remarkable progress and outstanding questions

β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.

The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance

Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.

P2888

leu.2017.179

P304

102-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1038/LEU.2017.179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P5530

20863908

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085885333

http://www.w3.org/2001/XMLSchema#string

P6409

153791794

http://www.w3.org/2001/XMLSchema#string

P698

28584253

http://www.w3.org/2001/XMLSchema#string

P932

5590713

http://www.w3.org/2001/XMLSchema#string

P953

117302